All news from Anaesthesiology

FDA Approves COPD Medication – Trelegy Ellipta

Trelegy Ellipta is a combination of fluticasone furoate, umeclidinium, and vilanterol.  FDA has approved this once-daily, single inhaler triple therapy for patients with COPD. According to a company news release, the approved indication includes patients with chronic bronchitis and emphysema. The patients who are on a fixed-dose combination of fluticasone furoate and vilanterol for air flow obstruction.

Risk of death increased when admitted to ICU at the weekend

Weekend effect: Mortality risk increased if admitted to intensive care units at the weekend compared to weekdays.

A study involving 119 Intensive Care Units (ICUs) in Austria reported a greater risk of death when admitted to the ICU at the weekend compared to a weekday. Alternately, the risk of dying in the ICU on the weekend was lower than on a weekday. This emphasized the complexity of the so-called 'weekend effect.' The study was published in the journal Critical Care.

Worldwide Bans on Highly Hazardous Pesticides Required

In rural Asia, highly hazardous pesticides are frequently used in acts of self-poisoning and suicide. However, two studies had reported that instead of concentrating on secure storage, global policies on highly hazardous pesticides should concentrate on National bans to decrease the suicidal cases.